Evidence map›Paper›PMID 33174088›Full record

ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2021

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support.

Tori Taylor, Christopher T Campbell, Brian Kelly

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Tori TaylorCollege of Pharmacy, University of Florida, Gainesville, FL, USA.
Christopher T CampbellDepartment of Pharmacy, Augusta University Medical Center, 1120 15th Street, Augusta, GA, 30912, USA. chrcampbell@augusta.edu.ORCID http://orcid.org/0000-0003-1625-1819
Brian KellyDepartment of Pharmacy, University of Florida Health Shands Hospital, Gainesville, FL, USA.
Augusta University · USUF Health Shands Hospital · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the use of mechanical circulatory support has increased in volume and complexity, anticoagulation remains an intricate component of a patient's pharmacotherapy plan. Traditionally, heparin has been the primary anticoagulant utilized because of its ease of titration and  familiarity of use. More recently, bivalirudin, a direct thrombin inhibitor, has attracted attention as a potential alternative to traditional therapy. While labeled for use in percutaneous coronary interventions, it is utilized off-label for heparin-induced thrombocytopenia and mechanical circulatory support. A literature search identified ten studies in which bivalirudin was used in extracorporeal membrane oxygenation and five studies in which it was used in ventricular assist devices. The purpose of this review was to summarize the currently available literature for bivalirudin use for mechanical circulatory support in both adult and pediatric patients.

Indexed as

Heart-Assist DevicesAdultAntithrombinsChildDose-Response Relationship, DrugDrug Administration ScheduleExtracorporeal Membrane OxygenationHirudinsHumansPeptide FragmentsRecombinant ProteinsAntithrombinsbivalirudinHirudinsPeptide FragmentsRecombinant Proteins

Identifiers

PMID33174088
PMCPMC7654565
OpenAlexW3099161989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.